We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
TEAM
Ananda is pleased to announce the following members of the team who are
working on the Licence application:
Science Lead
Dr Inbar Maymon Pomeranchik, Executive Director of Ananda. Inbar holds a PhD
in plant sciences molecular biology from the Hebrew University of Jerusalem.
Inbar is deeply embedded in the Israel medicinal cannabis research space and
has close ties with multiple cannabis research teams at major Israeli
universities and academies.
Licence Application Lead and Coordination
Dr Eli Schmell, Senior Advisor to Ananda. Dr Schmell holds a PhD in Cellular
and Molecular Biology from the Johns Hopkins University School of Medicine and
a BSc in Mathematics and Physics from the City University of New York. Dr
Schmell has over thirty years of direct, global and senior management
experience in all aspects of the BioPharma/Biotechnology industry. Most
notably, Dr Schmell held a senior management position in the US Navy’s
pharmaceutical program.
Genetics
Dr Hadar Less, Consultant to DJT Group, continuing his role for TAL. Dr Less
holds a PhD in plant science from the Weizmann Institute of Sciences and a MSc
in Physiology from the Israel Institute of Technology. Dr Less was previously
Agriculture Division manager at BOL Pharma (one of the eight Israeli cannabis
cultivators) and CEO of BOL Agrotech. He has also held multiple roles at seed
genetics giant, Syngenta.
Agriculture / Growing
Stuart Piccaver, CEO of JEPCO. Stuart is a third-generation farmer and CEO of
the second largest grower of salad leaves in the UK. Stuart is a leader in
agricultural innovation.
Dave Edwards, CEO of Anglia Salads, which is a grower of specialist salad
leaves for the ready to eat bagged salad market. Dave was directly
responsible for Anglia Salads’ previous cannabis growing activities.
Simon Goddard, CFO of JEPCO and Head of Compliance for the JEPCO Group of
Companies.
Our leading cannabis professor who is a partner
https://www.canna-tech.co/speakers/dr-david-meiri/
Nope, like I've said previously, I'm sitting happy as larry, c. 250% up at the moment. Intend to hold for the long term, might purchase again over the coming weeks. Your posts are entirely inconsequential to my investment strategy.
Now, back to the issue at hand: who's to say you're not currently ramping up an already volatile due to the fact that you're on a huge loss (here or elsewhere), and next week you'll be back to your "it's so undervalued; it's backed by death spiral finance" chat.
Our equal partner JEPCO who grew cannabis for GW Pharma
https://www.jepco.co.uk/
24 Feb 2021 18:32
Let’s make one thing clear ... I don’t have to share my research. The only reason I’m
Sharing it is because I had to post negative stuff to get the seller to move down the book. Now I’m filled I want to share my research for all the true investors. A way of saying sorry.
No one has put the effort and graft into doing research on ANA like me and it’s taken me many many days of looking into the company and that’s without all the time it’s taking me to put in on here .
I won’t be able to share it all with you in a day or even a week but if you leave my research thread clear I will add to it whenever I find time (that way any new lookers can find out all the information really easy).
I’m not going anywhere and will be here right to the end so let’s put everything behind us and move forwards.
(This was my post and the fact that I’ve been in the industry for nearly 27 years and bought in should tell you everything you need to know).
No hard feelings and once again I apologise but I had to do what I had to do and I was only getting a big player to move his price down .
I was the big buyer not only today but the other day and I’ve put my money where my mouth is (I own 1.7125% of the company)
ATB
Like I said it’s not a secret.
Did you sell your shares by any chance ?
Better buy back in before the license is granted lol.
Why don’t you put my post up where I apologised and explained myself ? Or Would you rather I do it ?
I’ve got nothing to hide what so ever , there was a big block seller and I wanted the price down as I was buying another 5m shares at the time . No one forced a gun to his head and only the fittest survive in this game so if you don’t like it ... TOUGH !
I have more than made up for it by sharing my research
Do what you like , it’s no secret that I wanted the seller to lower his price LOL.
I’ve posted the facts why we are massively undervalued . The market makes the price anyway .
You don’t get partners like JEPCO for nothing !!!!
You would be better off warning MXC and CBX shareholders because they are overvalued stocks and that’s why they are falling 10# a day .
If anyone listened to me they would have saved themselves money , ANA on the other hand is really undervalued and that’s why we are rising .
Are you genuinely asking people to repost and address all of the reasons that you put as to why this was a garbage, overvalued stock?
Strange why they are putting every buy as a sale today
200 TONS is worth £400m
50% goes to ANA = £200m
P/E x 10 = £2 billion
Current market cap £6.4m
ANA will be the no 1 cannabis stock here in the UK , just like Canopy Growth is in the USA.
I can’t emphasis how important first mover advantage is . We have every single aspect sown up and that’s the reason why we have attracted such big partners with all the credentials/ experience .
We have been set up to become the next GW Pharma , all you have to do is read every single rns and do in depth research into all the people / companies that are already involved / partners.
I strongly advise any new investor to do the above and join the dots ....
You won’t be disappointed, I assure you of that!!!!
If anyone can show me anything negative about this company then please share it because I have done major research and I can’t find anything at all.
GLA genuine investors